Abstract 【Objective】 To investigate the efficacy of transurethral vaporization of the prostate with 1470 nm laser (1470 nm DiLVP) in the treatment of patients with benign prostatic hyperplasia (BPH). 【Methods】A total of 114 patients with BPH admitted to our hospital from February 2019 to February 2022 were selected and divided into group A (receiving 1470 nm DiLVP treatment) and group B (receiving TUPKP treatment) based on different surgical plans, with 57 patients in each group. Perioperative parameters, maximum urinary flow rate (Qmax) before and after operation, IPSS score, residual urine volume (RUV), serum prostate specific antigen (PSA) level, stress factors [cortisol (Cor), adrenaline (AD), Norepinephrine (NE)] level and the incidence of complications were compared between the two groups.【Results】The hospitalization time, bladder flushing time, catheter retention time, and surgical time in the Group A were shorter than those in the Group B, and the intraoperative blood loss was lower than that in the Group B (P<0.05). The IPSS score, RUV, and PSA levels of the two groups of patients at 1 and 3 months after surgery were lower than those before surgery, while Qmax was higher than that before surgery (P<0.05); The IPSS score, RUV, and PSA levels in the Group A were lower than those in the Group B at 1 and 3 months after surgery, while Qmax was higher in the Group B (P<0.05). The serum NE, Cor, and AD levels were higher in both groups at 12 hours and 24 hours after surgery than those before, while the group A was lower than the group B, with statistically significant differences (P<0.05). The incidence of postoperative complications in the Group A was 1.75% (1/57), lower than the Group B [15.79% (9/57)], with a statistically significant difference (P<0.05). 【Conclusion】The application of 1470 nm DiLVP in the treatment of BPH can optimize perioperative indicators, improve patient condition, improve urinary control function, reduce postoperative complications, and have a smaller impact on the body's traumatic stress response.
SU Bin-jie,CHEN Gang. Clinical Efficacy of 1470 nm Laser Vaporization of the Prostate through Urethra in the Treatment of Benign Prostatic Hyperplasia[J]. JOURNAL OF CLINICAL RESEARCH, 2023, 40(7): 984-986.
2023, Vol. 40 
